ef
fi
cient
translat
basic
vaccin
research
clinic
therapi
greatli
depend
upon
avail
appropri
anim
model
test
novel
vaccin
candid
anim
model
critic
step
develop
modern
vaccin
anim
model
use
assess
qualiti
quantiti
immun
respons
identifi
optim
rout
deliveri
formul
determin
protect
infect
diseas
transmiss
evalu
safeti
toxic
vaccin
formul
anim
model
help
make
translat
basic
research
clinic
applic
often
allow
predict
vaccin
potenti
help
predict
fi
nancial
risk
vaccin
manufactur
choos
appropri
anim
model
becom
increasingli
import
fi
eld
model
advantag
disadvantag
review
criteria
select
right
anim
model
advantag
disadvantag
variou
anim
model
well
futur
need
anim
model
discuss
reduct
diseas
transmiss
plethora
anim
model
exist
rang
small
insect
larg
livestock
speci
hors
cattl
anim
model
use
investig
speci
fi
c
immun
mechan
traf
fi
cking
interact
effector
cell
use
assess
larger
aspect
vaccin
develop
induct
herd
immun
model
spread
certain
diseas
within
vaccin
popul
anim
model
rang
greatli
transgen
clone
anim
outbr
speci
surgic
model
facilit
access
certain
immun
compart
human
anim
neonat
age
anim
gnotobiot
wild
type
anim
use
model
singl
infect
versu
coinfect
chronic
diseas
autoimmun
disord
use
analyz
herd
immun
follow
vaccin
transmiss
amongst
infect
noninfect
anim
well
studi
transfer
passiv
immun
via
placenta
colostrum
milk
thu
choos
appropri
anim
model
critic
develop
modern
effect
vaccin
howev
use
anim
research
also
come
ethic
respons
treat
anim
best
possibl
way
avoid
suffer
unnecessari
pain
thu
use
anim
research
limit
circumst
model
exist
monitor
ethic
committe
involv
public
test
vaccin
anim
model
critic
step
vaccin
develop
often
critic
decis
point
long
process
develop
regist
vaccin
hundr
differ
model
avail
assess
variou
aspect
immun
respons
plethora
speci
strain
mutant
avail
studi
review
review
mani
countri
promot
replac
reduct
anim
experi
research
much
possibl
wile
et
al
howev
method
current
avail
test
induct
immun
respons
vaccin
use
anim
remain
critic
develop
vaccin
howev
choos
appropri
anim
model
crucial
success
project
long
run
save
anim
research
money
vaccin
evalu
one
point
small
rodent
like
mice
mice
advantag
readili
avail
low
cost
easi
handl
de
fi
ned
genet
background
immun
function
well
character
furthermor
abund
immunolog
reagent
exist
mice
allow
detail
analysi
immun
respons
vaccin
fewer
reagent
avail
speci
limit
level
detail
analysi
howev
larg
anim
speci
pig
cow
sheep
advantag
physiolog
immunolog
closer
relat
man
often
host
close
relat
pathogen
elahi
et
al
gerdt
et
al
moreov
larg
anim
speci
predominantli
outbr
import
develop
vaccin
normal
distribut
vaccin
respond
nonrespond
seen
genom
speci
sequenc
annot
bishop
et
al
fi
nal
process
annot
detail
overview
potenti
advantag
disadvantag
variou
speci
vaccin
research
provid
tabl
anim
model
group
model
use
assess
immun
respons
natur
diseas
model
surrog
diseas
model
surgic
experiment
model
model
vari
greatli
scope
cost
requir
special
infrastructur
model
assess
immun
respons
typic
includ
mice
small
rodent
case
base
use
speci
fi
c
strain
knockout
exampl
linkag
innat
acquir
immun
respons
vaccin
assess
use
mice
defect
innat
signal
pathway
trif
mice
assess
type
immun
respons
induc
speci
fi
c
vaccin
balbc
mice
versu
black
commonli
use
sinc
reagent
avail
assess
cytokin
secret
speci
fi
c
antibodi
isotyp
howev
numer
strain
avail
assess
immun
respons
mice
speci
commonli
use
includ
rabbit
rat
guinea
pig
advantag
model
abil
rapidli
assess
immun
respons
certain
antigen
commonli
use
larg
screen
test
adjuv
vaccin
formul
assess
best
rout
immun
speci
fi
c
strain
knockout
even
human
anim
use
assess
certain
qualiti
immun
respons
includ
shift
toward
helper
th
respons
induct
mucos
versu
system
immun
onset
durat
immun
etc
one
key
characterist
though
model
ca
nt
use
assess
protect
infect
thu
somewhat
limit
develop
vaccin
model
commonli
use
preclin
vaccin
develop
refer
use
speci
experiment
condit
infect
pathogen
interest
model
somewhat
arti
fi
cial
often
higher
infect
dose
arti
fi
cial
rout
infect
lack
clinic
symptom
use
howev
offer
advantag
work
anim
easili
hous
handl
costeffect
well
de
fi
ned
term
immun
system
often
mice
use
development
purpos
also
regulatori
point
view
regist
vaccin
product
allow
nonhuman
primat
costli
physiolog
similar
human
depend
speci
easi
access
mucos
site
mani
immun
compart
immun
function
well
de
fi
ned
outbr
speci
hemochori
placenta
type
costli
need
special
facil
train
immun
system
develop
post
partum
mhc
major
histocompat
complex
prr
pattern
recognit
receptor
screen
larg
number
candid
vaccin
rapid
ef
fi
cient
way
case
cost
effect
particular
abil
speci
fi
calli
knock
individu
gene
help
understand
speci
fi
c
immun
function
abil
adopt
transfer
immun
cell
one
anim
anoth
anoth
major
advantag
use
mice
surrog
model
recent
creation
human
mice
gener
transfer
human
stem
cell
fetal
anim
enhanc
potenti
surrog
model
vaccin
develop
macchiarini
et
al
shultz
et
al
howev
use
speci
surrog
model
becom
popular
exampl
cotton
rat
wide
accept
excel
model
respiratori
virus
ferret
use
model
fl
uenza
viru
infect
guinea
pig
domest
pig
use
tuberculosi
research
pig
use
number
pathogen
includ
enteromoeba
histolytica
girardmisguich
et
al
chlamydia
trichomati
hendra
viru
meuren
et
al
recent
develop
novel
model
pertussi
newborn
piglet
elahi
et
al
model
resembl
diseas
human
much
closer
allow
assess
vaccin
induc
immun
respons
well
studi
interact
bacterium
bordetella
pertussi
host
interestingli
pig
natur
host
b
bronchiseptica
thu
mani
result
directli
translat
develop
veterinari
vaccin
elahi
et
al
thu
use
surrog
model
mani
advantag
model
use
assess
immun
respons
vaccin
surrog
model
use
understand
role
variou
aspect
immun
respons
includ
innat
acquir
immun
mucos
versu
system
immun
well
traf
fi
cking
effector
cell
one
immun
compart
anoth
offer
major
advantag
fi
nding
correl
protect
experiment
challeng
infect
model
base
speci
fi
c
pathogen
natur
host
advantag
resembl
interact
host
pathogen
within
appropri
biolog
context
thu
natur
model
use
analyz
variou
aspect
immun
respons
immun
infect
includ
role
virul
factor
invas
penetr
toxic
well
host
immun
respons
pathogen
natur
diseas
model
includ
mani
larg
anim
speci
proven
success
strategi
develop
vaccin
human
anim
diseas
rous
kaistha
import
advantag
larg
anim
model
abil
use
natur
rout
challeng
therefor
obtain
relev
correl
immunemedi
protect
addit
use
larg
anim
model
one
fi
nd
highand
lowrespond
character
use
genom
proteom
kinom
analysi
jalal
et
al
wilki
mallard
vaccin
ef
fi
caci
also
vari
dramat
immun
young
elderli
lambert
et
al
lang
et
al
moxon
siegrist
natur
diseas
model
includ
parvoviru
e
coli
rotaviru
infect
pig
calv
use
establish
concept
matern
vaccin
effect
strategi
reduc
risk
infect
neonat
studi
identi
fi
ed
vaccin
strategi
optim
passiv
transfer
matern
immun
newborn
determin
durat
protect
follow
passiv
transfer
matern
antibodi
dobrescu
huygelen
kohara
et
al
mcnulti
logan
mostl
burki
result
concept
introduc
human
medicin
sever
vaccin
avail
immun
pregnant
mother
addit
candid
consid
sever
countri
world
blanchardrohn
siegrist
edward
poehl
et
al
anoth
major
advantag
natur
diseas
model
abil
studi
coinfect
two
pathogen
increas
evid
literatur
coinfect
substanti
contribut
establish
diseas
mani
case
respons
sever
complic
even
lethal
diseas
outcom
case
mani
viral
infect
typic
follow
secondari
bacteri
infect
howev
also
believ
case
two
viral
infect
hepat
b
c
viru
rodriguezinigo
et
al
other
sever
coinfect
model
well
establish
larg
anim
includ
model
respiratori
infect
cattl
combin
respiratori
bovin
coronavirus
rbcv
pasteurella
haemolytica
storz
et
al
bovin
herp
viru
mannheimia
hemolytica
model
yate
bovin
viru
diarrhea
viru
bvdv
mycoplasma
bovi
prysliak
et
al
name
exampl
includ
porcin
reproduct
respiratori
syndrom
viru
prrsv
streptococcu
sui
model
pig
xu
et
al
thu
use
natur
diseas
model
advantag
abl
studi
effect
multifactori
coinfect
host
use
explor
variou
aspect
vaccin
formul
deliveri
includ
rout
administr
target
speci
fi
c
receptor
induct
mucos
versu
system
immun
surgic
model
allow
access
speci
fi
c
immun
compart
intestin
lymph
node
skin
tissu
exampl
develop
intestin
gutloop
model
larg
anim
gerdt
et
al
use
assess
potenti
oral
vaccin
vivo
follow
origin
concept
thieryvella
loop
yardley
et
al
model
base
surgic
creation
independ
intestin
segment
remain
within
anim
month
without
alter
blood
lymph
support
gerdt
et
al
certain
period
time
segment
collect
immun
respons
segment
peyer
patch
lamina
propria
intestin
epithelium
assess
meuren
et
al
major
advantag
model
fact
loop
independ
thu
allow
assess
multipl
immun
respons
differ
vaccin
formul
within
anim
model
avail
number
speci
includ
calv
sheep
pig
even
chicken
aich
et
al
surgic
model
includ
cannul
blood
vessel
even
lymphat
allow
collect
larg
number
speci
fi
c
immun
cell
yen
et
al
exampl
pseudoaffer
lymph
especi
rich
dendrit
cell
collect
remov
lymph
node
subsequ
stenosi
affer
effer
lymphat
rothel
et
al
exampl
surgic
model
includ
insert
cathet
pump
vaccin
releas
speci
fi
c
site
slow
releas
time
even
placement
bolu
analyz
depot
effect
anim
model
also
use
assess
speci
fi
c
issu
vaccin
deliveri
topic
applic
safeti
toxic
vaccin
formul
individu
compon
thereof
case
requir
regulatori
author
often
requir
use
least
two
speci
show
safeti
case
small
rodent
howev
larg
anim
model
recogn
use
model
exampl
physiolog
skin
similar
human
pig
make
pig
good
model
studi
intracutan
topic
deliveri
vaccin
well
assess
safeti
novel
vaccin
formul
ethic
use
anim
vaccin
research
requir
choos
anim
resembl
diseas
close
possibl
help
address
speci
fi
c
issu
consid
everi
time
anim
experi
plan
three
exampl
consider
choos
appropri
anim
model
provid
vast
major
pathogen
enter
via
mucos
surfac
induct
system
mucos
immun
therefor
import
goal
futur
vaccin
model
requir
assess
whether
futur
vaccin
effect
induc
mucos
immun
gerdt
et
al
everi
anim
model
well
suit
assess
mucos
immun
respons
size
anim
oral
respiratori
tract
predetermin
access
mucos
tract
volum
inject
actual
rout
immun
exampl
intranas
vaccin
mice
often
associ
inhal
ingest
vaccin
antigen
make
dif
fi
cult
discrimin
intranas
oral
intrapulmonari
vaccin
contrast
larger
anim
model
use
control
deliveri
vaccin
nasal
passag
provid
easier
access
mucos
surfac
mucos
compart
gerdt
et
al
exampl
suf
fi
cient
quantiti
intraepitheli
lymphocyt
lamina
propria
lymphocyt
isol
mucos
surfac
pig
sheep
cattl
without
compromis
number
immun
cell
pool
cell
differ
compart
gerdt
et
al
inde
nasal
passag
sheep
cattl
close
resembl
human
display
similar
pattern
develop
hein
griebel
mutwiri
et
al
speci
mucos
immun
system
develop
well
birth
stand
clear
contrast
mice
mucos
immun
system
develop
birth
mention
intestin
model
develop
allow
control
vaccin
deliveri
speci
fi
c
mucos
site
includ
intestin
use
evalu
mucos
vaccin
deliveri
technolog
adjuv
gerdt
et
al
mutwiri
et
al
neonat
amongst
suscept
infecti
diseas
million
infant
young
children
die
everi
year
due
infect
infecti
pathogen
due
number
factor
includ
challeng
associ
develop
immun
system
inabl
respond
glycoconjug
vaccin
limit
access
vaccin
well
absenc
vaccin
devast
diseas
rsv
other
prabhuda
et
al
vaccin
research
speci
fical
neonat
howev
current
hamper
absenc
good
anim
model
studi
induct
immun
respons
immun
memori
context
neonat
immun
system
exampl
neonat
period
mice
much
shorter
man
make
use
mice
develop
neonat
vaccin
highli
problemat
number
larg
anim
model
may
repres
immun
system
ontogeni
human
elahi
et
al
exampl
use
fetal
lamb
model
abl
show
oral
immun
dna
vaccin
highli
effect
fetus
induc
strong
mucos
system
immun
respons
well
longterm
memori
develop
immun
system
gerdt
et
al
larg
anim
model
may
much
appropri
evalu
vaccin
immun
respons
neonat
address
question
regard
possibl
interact
vaccin
matern
antibodi
exampl
novel
vaccin
formul
includ
adjuv
area
rapid
develop
vaccin
research
area
vaccin
deliveri
human
anim
vaccin
move
away
needl
either
risk
broken
needl
meat
product
low
complianc
rate
young
children
infant
interestingli
recent
pandem
reveal
even
adult
inject
via
needl
becom
less
accept
public
thu
novel
strategi
vaccin
deliveri
requir
use
needlefre
injector
intraderm
patch
topic
applic
appropri
anim
model
requir
fi
rstli
resembl
skin
physiolog
human
secondli
allow
test
injector
time
allow
deliveri
vaccin
real
condit
tabl
pig
cow
frequent
use
assess
novel
vaccin
technolog
allow
intraderm
applic
even
larger
volum
vaccin
van
drunen
littelvan
den
hurk
et
al
needlefre
devic
electropor
van
drunen
littelvan
den
hurk
hannaman
shown
highli
effect
cattl
pig
van
drunen
littelvan
den
hurk
et
al
current
develop
practic
applic
devic
needlefre
injector
success
test
pig
anim
model
critic
develop
vaccin
requir
determin
qualiti
quantiti
immun
respons
vaccin
requir
assess
safeti
toxic
vaccin
formul
use
determin
ef
fi
caci
vaccin
provid
protect
challeng
infect
often
use
assess
potenti
prevent
diseas
transmiss
within
speci
fi
c
popul
thu
select
appropri
anim
model
speci
fi
c
need
research
project
critic
rather
driven
low
cost
eas
handl
research
look
model
close
resembl
target
speci
thu
produc
result
could
quickli
translat
real
product
long
term
larg
amount
money
time
resourc
save
way
